Effects of L-carnitine and pentoxifylline on the activity of lactate dehydrogenase [C.sub.4] isozyme and motility of testicular spermatozoa in mice.
Infertility is a common and worrisome problem for couples. About 30% to 50% of cases of infertility are due to male factors including sperm motility disorder (1). Physiological maturation of sperm and acquisition of motility are done during passage through epididymis; thus, immature sperm such as those from testicular sperm extraction (TESE) possess a little motility and fertilization capacity. Therefore, finding a way to increase sperm motility is essential for patients' TESE samples (2).
Studies have shown that sperm motility is dependent on the amount of its energy production. Under various conditions, mammalian sperm provide their energy requirements by anaerobic glycolysis, aerobic glycolysis and beta oxidation of endogenous substrates (including fatty acids). In the presence of oxygen, the end product of glycolysis is pyruvate and the lactic acid present in the female genital tract can be used as substrate by the sperm lactate dehydrogenase [C.sup.4] (LDH-[C.sub.4]) to produce pyruvate for the mitochondrial consumption. In anaerobic glycolysis, environmental glucose or fructose are used by sperm as a source of energy to release lactic acid by the LDH-[C.sub.4] activity (3-4). In aerobic conditions and lack of substrates for glycolysis, sperm gain the energy from the beta-oxidation of fatty acids in the context in which L-carnitine acts as a cofactor (5).
It has been shown that LDH-[C.sub.4] is a testis-specific isoenzyme (6) and it is present during spermatogenesis. LDH-[C.sub.4] appears in the cytosol of testicular cells, from spermatocytes to spermatids. Finally, LDH-[C.sub.4] will be placed in the middle and principal parts of mature spermatozoa (7) and also in the inner mitochondrial and plasma membrane of mature and developing spermatogenic cells in testis (8, 9). This isoenzyme plays an important role in the process of glycolysis and ATP production in sperm flagellum and, sperm motility. In addition, a disorder in LDH-[C.sub.4] gene has been reported to cause impaired sperm motility, followed by infertility in male mice (10).
Production of excessive free radicals due to laboratory manipulations, cellular waste products, presence of large numbers of leukocytes and immature germ cells is one of the most important issues to be considered in assisted reproductive technique (ART) procedures. Therefore, sperm samples prepared for ART cycles are susceptible to oxidative damage, especially when the samples are free of seminal plasma and exposed to low levels of protective antioxidants (11). Reactive oxygen species (ROS) have been shown to have an impact on cellular components such as the lipid, protein and carbohydrate components of the cell membrane (12). There are reports that ROS can damage sperm motility by interruption of ATP production or flagellar axonome phosphorylation (13). Immature sperm, such as those from testicular sperm extraction (TESE), produce much greater ROS than mature sperm (14).
Sperm stimulators, such as pentoxifylline (PTX) and L-carnitine (LC), are antioxidants and ROS scavengers (11). Extensive studies have been done in vivo and in vitro on different compounds, including LC and PTX, affecting sperm motility in ART (15-18). LC has a key role in sperm metabolism by supplying the required energy and has a positive effect on sperm production, maturation and motility (19). It has been suggested that high concentrations of L-carnitine in the epididymal fluid serves to stabilize the sperm plasma membrane (20). According to existing theories since 1994, PTX acts as a phosphodiesterase enzyme inhibitor and causes an increase in cellular cAMP concentration (21). In later stages, this increase could cause increased cellular glycolysis and ATP production which can promote sperm motility and lead to increased fertility rates (18). Other studies suggest that PTX can protect the sperm plasma membrane integrity (22). Despite widespread use of PTX in the culture media in IVF laboratories throughout the world, PTX is a toxic agent and can lead to a decrease in sperm survival if it is prescribed for longer than 90 min (23).
Considering the harmful effects of free radicals in the structural integrity of sperm membrane, ATP production, and ultimately sperm function, we used antioxidants to reduce oxidative stress. PTX, an anti-oxidant with toxic effects and LC, a non-toxic antioxidant, can prevent LDH[C.sub.4] damage in sperm. We subsequently evaluated mouse sperm motility and LDH[C.sub.4] enzyme activity after LC and PTX administrations.
Animals and Sperm Preparation: The animal experiments were approved by the Ethics Committee of Shiraz University of Medical Sciences. Fortyeight male balb/C mice weighing 25 to 30 g were acclimated to the laboratory condition (12 hr light, 12 hr darkness and a temperature of 22 to 24[degrees]C). We removed the testes of the animals and washed them by saline and Ham's F10 medium (Sigma, USA). The tunica albuginea was separated from the testes and seminiferous tubules were gently removed by two syringes. Red blood cells were separated by the addition of Ham's F10 to the samples and centrifugation at 500 rpm for 10 min. The palette was cut into pieces in Ham's F10 medium, and vortexed for 1 min to extract the sperm from the tubules (24). The sample was then incubated at room temperature for 1 hr (23), and centrifuged at 500 rpm for 10 min to precipitate the Leydig and Sertoli cells. The supernatant was centrifuged at 1200 rpm for 10 min and the palette which contained sperm was resuspended in 1 ml of Ham's F10 (24). Sperm count was done using a hemocytometer.
Experimental design: The sperm samples were pooled and aliquoted into three parts. Ham's F10 (0.2 ml), used as the control solution containing 3.6 mM of LC (Sigma, USA) or PTX (Sigma, USA), was added to the equal volume of aliquoted sperm samples. The final concentration of 1.76 mM of LC or PTX was obtained in the samples (17).
Sperm motility assay: Sperm motility was assessed 30 min after incubation at room temperature. All motility evaluations were performed according to the World Health Organization (WHO) guidelines (25). To evaluate sperm motility, sperm were classified as immotile (IM, no movement), non-progressive motile (NP, all other patterns of motility with an absence of forward progression, e.g. swimming in small circles, the flagella force hardly displacing the head, or when only a flagella beat can be observed) and progressively motile (PR, spermatozoa moves actively, either linearly or in a large circle, regardless of the speed) (25). The percentage of the motile sperm was calculated according to study done by Moreira et al. (26).
Lactate dehydrogenase [C.sub.4] assay: LDH-[C.sub.4] enzyme activity was measured by spectrophotometry. Sperm samples (6x[10.sup.6]/ml) were sonicated in 500 [micro]l Tris-HCl (0.1 M, pH=7) for 10 s, three times and centrifuged at 14,000 rpm at 4[degrees]C for 10 min. Ten [micro]l of the extract was added to 1 ml of reaction buffer (0.05 M [Na.sub.2]HP[O.sub.4] (Merck, Germany) pH=7, 0.1 mg/ml NADH (Sigma, USA), and 27.5 [micro]g/ml pyruvate (Sigma, USA). LDH-[C.sub.4] activity was calculated as the change in absorbance at 340 nm over a period of 1 min and expressed as U/ml.
Statistical analyses: All results were presented as mean [+ or -] SE (standard error of mean). Statistical analyses were performed using one-way analysis of variance (ANOVA), followed by Fisher's LSD test using SPSS version 15 for windows. A p-value less than 0.05 was considered as a statistically significant difference.
Effects of LC and PTX on sperm motility and LDH[C.sub.4] enzyme activity: The findings showed a significant increase in the percentage of progressive sperm exposed to PTX compared to the control sperm (p < 0.001) after 30 min of incubation. There was a significant decrease in the percentages of immotile sperm and a significant increase in the percentage of non-progressive sperm in the presence of LC and PTX compared with the control sample 30 min after incubation (p < 0.001). The data for sperm motility has been summarized in table 1.
[FIGURE 1 OMITTED]
As shown figure 1, LC-treated sperm had a significant increase (2.20 [+ or -] 0.12 U/ml; p=0.04) in mean LDH-[C.sub.4] enzyme activity compared with the controls (1.80 [+ or -] 0.13 U/ml) 30 min after incubation. In addition, the results (Figure 1) demonstrated a significant increase in the LDH-[C.sub.4] enzyme activity of PTX-treated sperm (2.27 [+ or -] 0.14 U/ml; p=0.01) after 30 min of incubation in comparison to the controls (1.80 [+ or -] 0.13 U/ml).
Improving the ability of sperm to fertilize the oocyte is the aim of many ART studies. In the testicular sperm extraction technique, it is important to have good quality, matured sperm for successful application of ART. Our findings showed that incubation of extracted sperm samples with LC or PTX led to both an increase in testicular sperm motility and LDH-[C.sub.4] enzyme activity compared to the control group.
Wang showed that LC can increase ejaculatory sperm motility of men with asthenozoospermia (27). In another study, Shi et al. also demonstrated that testicular sperm motility improved after exposure to LC in vitro (28).
Similarly, PTX has been reported to increase testicular sperm motility (17). Aliabadi et al. showed that mice testicular sperm motility can be improved after exposure to LC and PTX in vitro (16). Our findings in this study are consistent with all the aforesaid results.
L-carnitine increases sperm motility by affecting the metabolism of fatty acids (29). Fatty acid metabolism occurs in the mitochondria of sperm middle-piece. It has been demonstrated that LC regulates the amount of acetyl coenzyme A (30). Acetyl-CoA is necessary for tricarboxylic acid cycle and energy production (31). Therefore, the increased motility of sperm by LC in this study might be due to the effects of LC on oxidative phosphorylation and energy production. We also indicated that a significant increase in LDH-[C.sub.4] enzyme activity in LC- and PTX- treated sperm in comparison to the control group. LDH-[C.sub.4] catalyzes a reversible reaction that produces lactate in sperm (32). It supplies the required NA[D.sup.+] for glycolysis process and continuous production of ATP in anaerobic conditions. Immunohistochemical studies have shown that LDH-[C.sub.4] protein is present in the cytosol of spermatocyte, spermatid and the principal piece of spermatozoa (8) and also in the inner mitochondrial and plasma membrane of mature and developing spermatogenic cells in the testis (8, 9). It has been observed that increased ROS causes damage to the sperm membrane and its mitochondrial membrane due to lipid peroxidation in lipopolysaccaride-treated rat testis. LPS also decreases the LDH-[C.sub.4] enzyme activity. However, in this study treating sperm with LC inhibited the LPS-induced toxicity in the testis (9) and increased sperm motility and LDH-[C.sub.4] activity.
Gil-Guzman showed that immature sperm such as TESE produce much more ROS than mature sperm (13).
Oxidiative stress can influence cell membrane structures such as proteins (12). Therefore, Reactive oxygen species scavengers such as LC and PF may affect sperm metabolism (11), motility (15, 28) and its plasma membrane (20, 22). Other researchers have reported that ROS by interruption of ATP production or flagellar axonome phosphorylation can damage sperm motility (13). Dokmeci's study showed that LC, as an antioxidant, can decrease oxidative products in infertile men (high volumes of ROS in their seminal fluid) and affect both sperm maturation and motility (5).
Our findings support similar previous studies. It is hypothesized that LC either through its role in the oxidative phosphorylation pathway in the aerobic condition or by antioxidant effects in protecting LDH-[C.sub.4] from the damage by ROS production improves the capacity for energy production in sperm. Especially in anaerobic conditions which ATP is produced and supplied by glycolysis, the maintence ability of LDH-[C.sub.4] enzyme for supporting glycolysis process is important to sperm motility.
Pentoxifylline also acts as an anti-oxidant agent (17) and can protect the fresh sperm plasma membrane (33). In our study, the PTX effects on LDH[C.sub.4] activity and sperm motility were likely due to its antioxidant activity. It has been shown that PTX can increase testicular sperm motility when it is added to the medium (17). However, Tasdemir et al. showed that PTX can also increase sperm motility by inhibiting the activity of phos-phodiasterase diesterase enzyme to increase the intracellular concentration of cAMP, glycolysis and production of energy (34). It is possible that PTX, through raising intracellular cAMP, increases the activity of cAMP/PKA pathway that requires ATP for its function. Therefore the increased need for ATP in this pathway in sperm can stimulate glycolysis and LDH-[C.sub.4] enzyme activity to provide energy requirements of sperm.
In our study both LC and PTX increased the motility and LDH-[C.sub.4] enzyme activity of sperm; however, LC is normally seen in epidydimis and testicular sperm is exposed to it (20). In addition, our previous work showed that LC administration could improve nuclear maturation more effectively than PTX (16).
In our study, in vitro administration of L-carnitin and pentoxifylline to extracted testicular sperm samples led to increased sperm motility and LDH-[C.sub.4] enzyme activity. Application of non-toxic antioxidant, L-carnitin is more suitable for ART protocol than PTX.
This study was supported by a grant, No. 5881, from Shiraz University of Medical Sciences in Shiraz, Iran for Ms Fatemeh Karimi's thesis in fulfilling her master's degree in anatomy.
Conflict of Interest
None of the authors had any conflict of interest.
(1.) Isidori AM, Pozza C, Gianfrilli D, Isidori A. edical treatment to improve sperm quality. Reprod Biomed Online. 2006; 12(6):704-14.
(2.) Su LM, Palermo GD, Goldstein M, Veeck LL, Ros enwaks Z, Schlegel PN. Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia: testicular histology can predict success of sperm retrieval. J Urol. 1999; 161(1): 112-6.
(3.) Mann T, Lutwak-Mann C. Studies on the metabolism of semen. 4. Aerobic and anaerobic utilization of fructose by spermatozoa and seminal vesicles. Biochem J. 1948; 43(2):266-70.
(4.) Storey BT. Mammalian sperm metabolism: oxygen and sugar, friend and foe. Int J Dev Biol. 2008; 52(5 6):427-37.
(5.) Dokmeci D. Oxidative stress, male infertility and the role of carnitines. Folia Med. 2005; 47(1):26-30.
(6.) Miki K, Qu W, Goulding EH, Willis WD, Bunch DO, Strader LF, et al. Glyceraldehyde 3-phosphate dehydrogenase-S, a sperm-specific glycolytic enzyme, is required for sperm motility and male fertility. Proc Natl Acad Sci U S A. 2004; 101(47): 16501-6.
(7.) Li SS. Lactate dehydrogenase isoenzymes A (muscle), B (heart) and C (testis) of mammals and the genes coding for these enzymes. Biochem Soc Trans. 1989; 17(2):304-7.
(8.) Duan C, Goldberg E. Inhibition of lactate dehydrogenase [C.sub.4] (LDH-[C.sub.4]) blocks capacitation of mouse sperm in vitro. Cytogenet Genome Res. 2003; 103(3 4):352-9.
(9.) Abd-Allah AR, Helal GK, Al-Yahya AA, Aleisa AM, Al-Rejaie SS, Al-Bakheet SA. Pro-inflammatory and oxidative stress pathways which compromise sperm motility and survival may be altered by L carnitine. Oxid Med Cell Longev. 2009; 2(2):73-81.
(10.) Odet F, Duan C, Willis WD, Goulding EH, Kung A, Eddy EM, et al. Expression of the gene for mouse lactate dehydrogenase C (Ldhc) is required for male fertility. Biol Reprod. 2008; 79(1):26-34.
(11.) Sikka SC. Relative impact of oxidative stress on male reproductive function. Curr Med Chem. 2001; 8(7):851-62.
(12.) Chaudiere J. Some chemical and biochemical constraints of oxidative stress in living cells. In: Riee-Evans CA, Burdon RH, editors. Free radical damage and its control. Amsterdam: Elsevier; 1994. p. 25-66.
(13.) Aitken RJ, Baker MA. Oxidative stress, sperm survival and fertility control. Mol Cell Endocrinol. 2006; 250(1-2):66-9.
(14.) Gil-Guzman E, Ollero M, Lopez MC, Sharma RK, Alvarez JG, Thomas AJ Jr, et al. Differential production of reactive oxygen species by subsets of human spermatozoa at different stages of maturation. Hum Reprod. 2001; 16(9):1922-30.
(15.) Lenzi A, Sgro P, Salacone P, Paoli D, Gilio B, Lombardo F, et al. A placebo-controlled doubleblind randomized trial of the use of combined lcarnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004; 81(6): 1578-84.
(16.) Aliabadi E, Soleimani-Mehranjani M, Borzoei Z, Talaei-Khozani T, Mirkhani H, Tabesh H. Effects of L-carnitine and L-acetyl-carnitine on testicular sperm motility and chromatin quality. Iran J Reprod Med. 2012; 10(2):77-82.
(17.) Kovacic B, Vlaisavljevic V, Reljic M. Clinical use of pentoxifylline for activation of immotile testicular sperm before ICSI in patients with azoospermia. J Androl. 2006; 27(1):45-52.
(18.) Tournaye H, Janssens R, Devroey P, van Steirteghem A. The influence of pentoxifylline on motility and viability of spermatozoa from normozoospermic semen samples. Int J Androl. 1994; 17(1):1-8.
(19.) Zare Z, Eimai H, Mohammadi M, Mofid M, dashtnavard H. The effect of orally administered lcarnitine on testis tissue, sperm parameters and daily sperm productionin adult mice. Cell J. 2010; 11(4):382-9.
(20.) Jenkins DL, Griffith OW. Antiketogenic and hypoglycemic effects of aminocarnitine and acylamino-carnitines. Proc Natl Acad Sci U S A. 1986; 83(2): 290-4.
(21.) Beshay E, Croze F, Prud'homme GJ. The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo. Clin Immunol. 2001; 98(2):272-9.
(22.) Gavella M, Lipovac V, Marotti T. Effect of pentoxifylline on superoxide anion production by human sperm. Int J Androl. 1991; 14(5):320-7.
(23.) Sato M, Ishikawa A. Room temperature storage of mouse epididymal spermatozoa: exploration of factors affecting sperm survival. Theriogenology. 2004; 61(7-8):1455-69.
(24.) Balaban B, Urman B, Isiklar A, Alatas C, Aksoy S, Mercan R, et al. Progression to the blastocyst stage of embryos derived from testicular round spermatids. Hum Reprod. 2000; 15(6):1377-82.
(25.) World Health Organization. WHO Laboratory manual for examination of human semen and spermcervical mucuinteraction. 4th ed. Cambridge: Cambridge University press; 2010.
(26.) Moreira SG, Lipshultz LI. Management of male infertility. Sci World J. 2004; 4:214-448.
(27.) Wang YX, Yang SW, Qu CB, Huo HX, Li W, Li JD, et al. [L-carnitine: safe and effective for asthenozoospermia]. Zhonghua Nan Ke Xue. 2010; 16(5):420-2. Chinese.
(28.) Shi JZ, Zhang SS, Zhang Z, Liang Q, Shi Y, Hua JL, et al. [Expressions of sperm-specific genes in carnitine-cultured testis sperm of obstructive azoospermia patients]. Zhonghua Nan Ke Xue. 2010; 16(6):504-9. Chinese.
(29.) Jeulin C, Lewin LM. Role of free L-carnitine and acetyl-L-carnitine in post-gonadal maturation of mammalian spermatozoa. Hum Repord Update. 1996; 2(2):87-102.
(30.) Brooks DE. Carnitine, acetylcarnitine and the activity of carnitine acyltransferases in seminal plasma and spermatozoa of men, rams and rats. J Reprod Fertil. 1979; 56(2):667-73.
(31.) Casillas ER, Chaipayungpan S. The distribution of carnitine and acetylcarnitine in the rabbit epididymis and the carnitine content of rabbit spermatozoa during maturation. J Reprod Fertil. 1979; 56(2): 439-44.
(32.) Burgos C, Maldonado C, Gerez de Burgos NM, Aoki A, Blanco A. Intracellular localization of the testicular and sperm-specific lactate dehydrogenase isozyme [C.sub.4] in mice. Biol Reprod. 1995; 53(1):84 92.
(33.) Tanphaichitr N. In vitro stimulation of human sperm motility by acetylcarnitine. Int J Fertil. 1977; 22(2):85-91.
(34.) Tasdemir I, Ta[section]demir M, Tavukcuoglu S. Effect of pentoxifylline on immotile testicular spermatozoa. J Assist Reprod Genet. 1998; 15(2):90-2.
Elham Aliabadi , Fatemeh Karimi , Mozhgan Rasti , Masoumeh Akmali , Tahereh Esmaeilpour 
-Department of Anatomy, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
-Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
* Corresponding Author: Mozhgan Rasti, Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Received: Jul. 22, 2012
Accepted: Dec. 9, 2012
Table 1. Mouse testicular sperm motility after 30 min of exposure to L-carnitine and Pentoxifylline (Mean [+ or -] SE) Experimental Sperm motility (% [+ or -] SE) groups Immotile Control 71.80 [+ or -] 1.5 L-carnitine 52.67 [+ or -] 1.2 * Pentoxifylline 45.47 [+ or -] 1.08 * ([dagger]) Experimental Sperm motility (% [+ or -] SE) groups Non-progressive Control 27.70 [+ or -] 1.4 L-carnitine 46.48 [+ or -] 1.1 * Pentoxifylline 52.86 [+ or -] 1.09 * ([dagger]) Experimental Sperm motility (% [+ or -] SE) groups Progressive Control 0.16 [+ or -] 0.16 L-carnitine 0.54 [+ or -] 0.18 Pentoxifylline 1.44 [+ or -] 0.26 * ([dagger]) * Significant difference from the controls (p < 0.001) * Significant difference from the controls (p < 0.001) ([dagger]) Significant difference from LC-treated group (p < 0.01)
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Original Article|
|Author:||Aliabadi, Elham; Karimi, Fatemeh; Rasti, Mozhgan; Akmali, Masoumeh; Esmaeilpour, Tahereh|
|Publication:||Journal of Reproduction and Infertility|
|Date:||Apr 1, 2013|
|Previous Article:||Aspects of psychosocial development in infertile versus fertile men.|
|Next Article:||In vitro human embryo culture; when questions outweigh answers.|